{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Deerfield",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80964",
      "recalling_firm": "Takeda Development Center Americas, Inc.",
      "address_1": "1 Takeda Pkwy",
      "address_2": "4034BB1",
      "postal_code": "60015-5713",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "AR, LA, MS, NC, NJ, OH, PA, SC and Puerto Rico",
      "recall_number": "D-0026-2019",
      "product_description": "Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Takeda Pharmaceuticals  America, Inc, Deerfield, IL 60015.  NDC: 64764-510-30",
      "product_quantity": "7,248 bottles",
      "reason_for_recall": "Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.",
      "recall_initiation_date": "20180910",
      "center_classification_date": "20181015",
      "termination_date": "20200413",
      "report_date": "20181017",
      "code_info": "Lot, expiry:  A26004, exp Apr 2020;  A26443 and A26444, exp Sep 2020",
      "more_code_info": ""
    }
  ]
}